5 results
DEFA14A
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Additional proxy soliciting materials
9:06am
in early-stage trials in immuno-oncology. He is currently a Special Volunteer at the National Cancer Institute’s Lymphoid Malignancies Branch. He also works
8-K
RNAC
Cartesian Therapeutics Inc
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
in immuno-oncology. He is currently a Special Volunteer at the National Cancer Institute’s Lymphoid Malignancies Branch. He also works as an Instructor
8-K
EX-99.1
RNAC
Cartesian Therapeutics Inc
10 Mar 22
Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
8:00am
volunteer clinical trial conducted with our partner AskBio, we evaluated a single dose of ImmTOR combined with an AAV8 empty capsid and observed
- Prev
- 1
- Next